Clinical Trial

A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population

Study acronym: Accept cfDNA
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this research is to collect blood samples and data from kidney transplant patients. The samples and data will be used for research and development of non-invasive test to detect donor-derived cell-free DNA (dd-cfDNA) in kidney transplant patients to evaluate the status of the transplanted organ.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-28; most recent amendment 2025-12-15.
Status change: Not Yet Recruiting → Recruiting 2025-11-17
Trial Details
NCT Number NCT07006831
Lead Sponsor Devyser Inc.
Conditions Kidney Disease, Kidney Transplant, Transplant Recipient, Renal Function, Cell-free DNA, NGS
Enrollment 400 participants
Start Date 2025-11-14
Primary Completion 2026-12 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2025-12-17